Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity
article
OA: closed
CC0
⤵ 20 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated how danazol and gestagen affect testosterone levels and the binding capacity of sex hormone-binding globulin.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic Properties via openalex
- Danazol Binding to Rat Androgen, Glucocorticoid, Progesterone, and Estrogen Receptors: Correlation With Biologic Activity via openalex
- Danazol: endocrine and endometrial effects. via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol plasma concentration in man. via openalex
- Effects of danazol and lynestrenol on serum lipoproteins in endometriosis via openalex
- Effects of danazol in the treatment of severe endometriosis. via openalex
- Metabolic effects of danazol. via openalex
- Pharmacology of danazol. via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- [The new synthetic gestagen danazol in the treatment of endometriosis, fibrosystic disease of the breast and prolonged primary infertility (author's transl)]. via openalex
- doi:10.1016/0003-2697(67)90297-7 via openalex
- W4285719527 via openalex
- W6640086787 via openalex
- W6793613985 via openalex
- W6980583568 via openalex
- doi:10.1097/00019616-199102000-00012 via openalex
- doi:10.1111/j.1749-6632.1949.tb27297.x via openalex
- doi:10.1177/030006057700500101 via openalex
- doi:10.1016/0009-8981(67)90032-0 via openalex
- doi:10.1111/j.1365-2265.1983.tb00739.x via openalex
- doi:10.1016/0010-7824(76)90007-x via openalex
- doi:10.1042/bj0500370 via openalex
- W1907235146 via openalex
- doi:10.1111/j.1365-2265.1979.tb03030.x via openalex
- doi:10.1111/j.1365-2265.1974.tb03298.x via openalex
- doi:10.1177/030006057700500103 via openalex
- doi:10.1677/joe.0.0620605 via openalex
- doi:10.1093/clinchem/11.4.478 via openalex
- doi:10.1016/0022-4731(73)90070-8 via openalex
- doi:10.1111/j.1365-2265.1981.tb02966.x via openalex
- doi:10.1210/jcem-43-1-244 via openalex
- doi:10.1016/0022-4731(80)90208-3 via openalex
Cited by (20)
- Danazol 2022
- Paradigm Shift: The Realization of New Medical Alternatives to Surgery for Endometriosis 2016
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile 2007
- Changing concepts of medical treatment of endometriosis 1993
- Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol 1991
- The use of danazol as a treatment of endometriosis 1991
- Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si1.gif" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mtext>D</mml:mtext><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mtext>Trp</mml:mtext></mml:mrow><mml:mn>6</mml:mn></mml:msup><mml:mo>,</mml:mo><mml:mtext>des</mml:mtext><mml:mo>-</mml:mo><mml:mtext>Gly</mml:mtext><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math>LH-RH ethylamide 1990
- Glucose tolerance and insulin resistance after danazol treatment 1989
- Placebo-controlled comparison of danazol and high-dose medroxypro-gesterone acetate in the treatment of endometriosis after conservative surgery 1987
- Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis 1987
- Cytoplasmic and nuclear estrogen binding capacity in the rat uterus during treatment with danazol and testosterone 1986
- Subcellular distribution and selectivity of the protein-binding component of the recognition system for sex-hormone-binding protein-estradiol complex in human decidual endometrium 1986
- Inhibitory effects of danazol on steroidogenesis in cultured human granulosa cells 1986
- Gynecologic Problems of Adolescence 1985
- Effects of progesterone, progestogens, and danazol on the specific cortisol binding in human plasma 1985
- Plasma lipoproteins during and after danazol treatment 1984
- Cytosol estrogen and progestin receptor concentrations and 17β‐hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue 1984
- Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women 1984
- Changes in the shbg concentration during danazol treatment 1984
- Free testosterone levels during danazol therapy 1983
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-05-13T18:37:28.025090+00:00
- pubmed
- last seen: 2026-05-13T22:10:00.881616+00:00
License: CC0
· commercial use OK